Rapport Therapeutics Return on Net Operating Assets Insights

Rapport Therapeutics, Inc. (RAPP)

32.38 -1.20 (-3.57%) USD | NASDAQ | Apr 06, 16:00

32.41 +0.03 (+0.09%) After-Hours: 20:00

View Return on Net Operating Assets for RAPP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

EyePoint Plc	Upgrade
Praxis Precision Medicines, Inc.	Upgrade
Bridgebio Oncology Therapeutics, Inc.	Upgrade
Olema Pharmaceuticals, Inc.	Upgrade
Arcellx, Inc.	Upgrade